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Abstract
Objectives: The aim of this study was to evaluate the immunoexpression of TWIST and p-Akt proteins in oral 
leukoplakia (OL) and oral squamous cell carcinoma (OSCC), correlating their expressions with the histological 
features of the lesions. 
Study design: Immunohistochemical studies were carried out on 10 normal oral epithelium, 30 OL and 20 OSCC 
formalin-fixed, paraffin-embedded tissue samples. Immunoperoxidase reactions for TWIST and p-Akt proteins 
were applied on the specimens and the positivity of the reactions was calculated for 1000 epithelial cells. 
Results: Kruskal-Wallis and Dunn’s post tests revealed a significant difference in TWIST and p-Akt immuno-
expression among normal oral mucosa, OL and OSCC. In addition, a significant positive correlation was found 
between TWIST and p-Akt expressions according to the Pearson’s correlation test. 
Conclusions: The results obtained in the current study suggest that TWIST and p-Akt may participate of the multi-
step process of oral carcinogenesis since its early stages.
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Introduction
Oral squamous cell carcinoma (OSCC) is the most 
prevalent malignancy of the oral cavity usually asso-
ciated with a poor prognosis (1). Most cases of OSCC 
are preceded by visible changes of the oral mucosa 
(2). Therefore, it would be important to identify those 
changes that may represent an early stage of the process 
of malignant transformation (3). Oral leukoplakia (OL) 
is considered the most prevalent potentially malignant 
lesion of the oral mucosa (4,5). This term should be used 
to recognize white plaques of questionable risk hav-
ing excluded (other) known diseases or disorders that 
carry no increased risk for cancer (4). The presence of 
epithelial dysplasia seems to be an important prognos-
tic indicator of malignant transformation (3). However, 
accuracy of dysplasia grading is dependent on the qua-
lity of the specimen and the location of the lesion where 
the biopsy was done. In addition, this grading system is 
also too subjective, with inter and intra-observers vari-
ability (6,7). Therefore, studies evaluating the effective-
ness of molecular markers in predicting the prognosis of 
premalignant lesions are relevant (8).
Recent studies evaluated the role of different molecular 
markers as adjuvants in identifying the malignant poten-
tial of potentially malignant oral lesions presenting dif-
ferent degrees of epithelial dysplasia (9-11). Hence, p-Akt 
(protein kinase B) protein has been the target of different 
studies (9,10) and it has been considered an important on-
cogene responsible for the development of a wide variety 
of malignancies (9,12), including OSCC (9).
TWIST is a basic helix-loop-helix highly conserved 
transcription factor that plays a key role in the progres-
sion of a primary tumor to the metastatic stage (13). It has 
been reported that TWIST may serve as an independent 
prognostic marker for predicting distant metastasis and 
the survival rate of patients affected by esophageal 
squamous cell carcinoma (14). TWIST also seems to 
play an important role in OSCC progression and lymph 
node metastasis (15). A recent study showed that p-Akt 
is a transcriptional regulatory target of TWIST in breast 
cancer cells, and its activation resulted in cell survival, 
migration and invasion (16).
The aim of this study was to evaluate the immunoexpres-
sion of TWIST and p-Akt proteins in OL and OSCC, with 
the purpose of verifying the participation of these proteins 
in the malignant transformation of oral epithelium.
Materials and Methods
-Specimens 
Thirty paraffin-embedded tissue samples of OL (Mild 
dysplasia n=10, moderate dysplasia n=10 and severe 
dysplasia n=10), 20 of OSCC and 10 of normal oral mu-
cosa obtained from the floor of the mouth, tongue, pa-
late and gingival of 41 males and 19 females, all smo-
kers, with a mean age of 47.6 year-old, were selected 
from the surgical pathology archives of the Department 
of Oral Pathology of the University of São Paulo. The 
samples were submitted to 5μm histological sections, to 
routinely staining with haematoxylin and eosin (H&E) 
and analyzed under light microscopy. The histological 
grades of oral dysplasia were determined by two inde-
pendent oral pathologists according to the World Health 
Organization (WHO) criteria (17) in a blinded fashion. 
Any discrepancies in the findings were analyzed and 
discussed among the observers for a final evaluation. 
-Immunohistochemical staining and evaluation
Three-µm 4% formalin-fixed slides were dewaxed with 
xylene and hydrated in ethanol series. For antigen re-
trieval, sections that received the antibody anti-TWIST 
were immersed in 10 mM monohydrated citrate buffer 
solution (pH 6.0) and heated in microwave oven at 95°C 
for 15 minutes. Slides that received the antibody anti-
p-Akt 1 ⁄ 2 ⁄ 3 were immersed in 10 mM monohydrated 
citrate buffer solution (pH 6.0), in water-bath at 95°C for 
30 minutes. Peroxidase activity was blocked with 6% 
hydrogen peroxide and methanol solution in two baths 
of 15 minutes each at room temperature. After washing 
with Tris buffer (pH 7.4), the slides were  incubated with 
the primary antibodies anti-TWIST (H-81 – Sc:15396; 
Santa Cruz Biotechnology, CA, USA), dilution 1:100, 
incubated at 4°C overnight,  and anti-p-Akt 1 ⁄ 2 ⁄ 3 (Thr 
308 – Sc:16646-R; Santa Cruz Biotechnology, Santa 
Cruz, CA, USA), dilution 1:100, incubated at room tem-
perature for  60 minutes. The slides were subsequently 
exposed to the avidin-biotin complex (LSAB-Kit + 
HRP; Dako Cytomation, Carpinteria, CA, USA) and 
to the 3,3’-diaminobenzidin chromogen (DAB+; Dako 
Cytomation, Carpinteria, CA, USA). The sections were 
counterstained with Meyer haematoxylin, dehydrated 
in ethanol, cleared in xylene and mounted. Breast can-
cer tissues were used as positive control for TWIST and 
prostate adenocarcinoma sections for p-Akt protein. The 
negative control was obtained by omitting the primary 
specific antibody during the reaction. The immunohis-
tochemical sections were analyzed by one independent 
blind and calibrated observer under light microscopy 
at 400x magnification. Five histological fields were 
randomly chosen and 1000 cells were counted in each 
slide. The analysis was carried out taking in count the 
number of positive cells in cytoplasmatic and/or nuclear 
compartments.
-Statistical analysis
The statistical analysis was performed using BioEstat 5.0 
software (Mamirauá Institute, Belém, PA, Brazil). Pos-
sible differences in TWIST and p-Akt immunoexpres-
sion among the five groups studied were verified by non-
parametric variance method, the Kruskal-Wallis test. 
Dunn’s post test was applied to determine which groups 
significantly differed from each other in respect to the 
means. Pearson’s correlation test was used to determine 
Med Oral Patol Oral Cir Bucal. 2012 Jan 1;17 (1):e29-34.                                                                                                                                      TWIST and p-Akt expression in oral carcinogenesis
e31
the possible existence of correlation between TWIST and 
p-Akt expression. The p-value < 0.05 was considered to 
be statistically significant. This study was approved by 
the ethical committee of the University of São Paulo. 
Results
Kruskal-Wallis test showed a statistically significant 
variance in TWIST immunoexpression among the five 
groups (P< 0.01). Dunn’s post test pointed significant 
differences in TWIST immunoexpression between nor-
mal oral mucosa and OSCC (P= 0.0001), mild dysplasia 
and OSCC (P= 0.0022), moderate dysplasia and OSCC 
(P= 0.0075), and between severe dysplasia and OSCC 
(P= 0.0071). It was also observed differences in TWIST 
expression between moderate dysplasia and severe dys-
plasia (P= 0.0475). However, no significant differences 
were observed between normal oral mucosa and mild 
dysplasia, and between mild dysplasia and moderate 
dysplasia (Fig. 1). TWIST immunoreaction in normal 
oral mucosa and in all OL groups (mild, moderate and 
severe dysplasia) was predominantly found in the para-
basal and basal layers, showing a cytoplasmatic stain-
ing. In OSCC, TWIST showed a diffuse distribution in 
neoplastic islands, with a higher expression in poorly 
Fig. 1. A) TWIST expression (positive cells) among the 
normal oral mucosa, OL and OSCC groups.
B) p-Akt expression (positive cells) among the normal oral 
mucosa, OL and OSCC groups
differentiated tumors, mainly revealing a citoplasma-
tic localization (Fig. 2); however, nuclear staining was 
sometimes also observed.
p-Akt immunoexpression, according to the Kruskal-
Wallis test, showed a significant difference among the 
five groups (P= 0.0083). Dunn’s post test pointed signi-
ficant differences in p-Akt immunoexpression in nor-
mal oral mucosa if compared to the three OL groups 
(mild, moderate and severe epithelial dysplasia) (P< 
0.01), and between the three OL groups and OSCC (p< 
0.05). There was no statistical difference among the 
three OL groups (Fig. 1). 
In the normal oral mucosa, p-Akt staining was observed 
to be restricted to the nucleus and limited to the basal 
and parabasal cells. In OL groups, p-Akt was also res-
tricted to the nucleus, but it was present in almost all 
epithelial layers. Finally, in OSCC group, p-Akt immu-
noexpression was found in both cellular compartments, 
with diffuse localization in both central and peripheral 
areas of tumor islands (Fig. 2). 
There was a significant positive correlation between 
TWIST and p-Akt immunoexpression in normal oral 
mucosa, OL and OSCC (Pearson’s correlation test, r= 
0.8741, P= 0.0426) (Fig. 3).
Fig. 2. Immunoexpression of TWIST and p-Akt proteins (streptavi-
dine-biotine). A) TWIST expression in oral epithelium with moder-
ate dysplasia (x400). B) TWIST expression in oral epithelium with 
severe dysplasia (x400). C) TWIST expression in OSCC (x200). D) 
p-Akt expression in oral epithelium with moderate dysplasia (x200). 
E) Oral epithelium with severe dysplasia (x200). F) p-Akt expression 
in OSCC (x400).
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Fig. 3. Scatter plot illustrating the positive association between 
TWIST and p-Akt expression under Pearson’s correlation test.
Discussion
The development of OSCC is associated with genetic 
changes that result in absence of controlling mecha-
nisms related to cell growth and differentiation (2). 
Studies have shown that these genetic alterations are 
also present in premalignant lesions, suggesting a 
possible role in the malignant transformation process 
(9,18). The present study showed significant differences 
in TWIST and p-Akt proteins expression among nor-
mal oral mucosa, OL and OSCC, suggesting that these 
two proteins may participate in the multi-step process 
of oral carcinogenesis. To our knowledge, this is the 
first study to evaluate TWIST expression in OL. Inte-
restingly, TWIST immunoreaction in all OL groups was 
predominantly found in the parabasal and basal layers, 
where these regions are known to initiate the dysplastic 
changes in OL (19).
Progression of OSCC may be associated with loss of 
E-cadherin, resulting in a more invasive phenotype 
(20). TWIST acts in EMT as a repressor of E-cadherin, 
promoting the loss of cell-to-cell adhesion and causing 
a dramatic remodeling of cytoskeleton, increasing cell 
motility (21). This may explain the phenotypic change 
found in TWIST positive cells in our study.
TWIST, a highly conserved basic helix-loop-helix tran-
scription factor, that was found to be a key factor in 
the promotion of metastasis of cancer cells, is known 
to induce epithelial-mesenchymal transition (EMT), a 
recently identified event implicated in tumor metasta-
sis, and to promote cancer cell invasion, both important 
steps in cancer progression (22). TWIST participation 
in cancer progression and metastasis has been reported 
in a variety of tumors, including  breast cancer (16), 
prostatic cancer (22), pancreatic cancers (23), gastric 
cancer (21), cervical cancer (24), bladder cancer (13,25) 
and OSCC (15,26). However, little is known about its 
involvement in the progression of OSCC.
TWIST immunoexpression was found in the cytoplasm 
and nucleus of the head and neck squamous cell carcino-
ma specimens, but no assumption was made about these 
findings (15). In our study, TWIST was mainly found in 
the cytoplasm of normal oral mucosa and OL. In OSCC 
TWIST protein was mostly observed in the cytoplasm; 
however, a nuclear staining was also observed in a few 
cases, similar to the reported by Ou et al. (15). In OSCC 
group, TWIST expression was related with differentia-
tion status, with a higher immunoexpression in poorly 
differentiated tumors.
According to Yuen et al. (22), increased cytoplasmatic 
immunostaining of TWIST is positively associated with 
neoplastic transformation in prostatic tissue. This in-
creased cytoplasmatic expression might play a negative 
role in the regulation of prostatic cancer cell differentia-
tion, whereas increased nuclear expression of TWIST 
may play a positive role in promoting metastasis. Simi-
lar findings were found in the current study, supporting 
the possible participation of TWIST in OSCC progres-
sion and its possible value as a prognostic marker. 
TWIST seems to be a pivotal transcription factor that 
may positively regulate the expression of CXCR4 and 
CCR7 genes during lymph node metastasis, and its 
expression is significantly correlated with the clinical 
stage of head and neck squamous cell carcinoma (15). 
It has been reported that CXCR4 can be up-regulated 
through NF-kB in prostate and breast carcinomas (15, 
27). Additionally, PI3K/Akt pathway activation seems 
to induce EMT via CXCR4 (28). Strong evidence shows 
that PI3K/Akt is required for activation of NFκB in-
duced by TNF and interleukin 1 (IL-1), or through Ras 
protein with the activation of IKKβ (29). 
Recent studies suggest that TWIST is involved with p-
Akt pathways (26,30).  Both TWIST and p-Akt were as-
sociated with the downregulation of E-cadherin and the 
loss of cell-to-cell adhesion in EMT (22,26). Increased 
TWIST expression may influence p-Akt pathway 
through unclear mechanisms in nasopharyngeal carci-
noma cells. However, this cross-talk may be explained 
by the possible interference of TWIST and p-Akt in 
the p53/MDM-2 pathway (30). Other study showed that 
p-Akt inhibition could induce the mesenchymal-to-
epithelial reverting transition through interaction with 
NF-kB and downregulation of TWIST in OSCC cells 
(26), suggesting that there may be a positive interaction 
between TWIST and p-Akt during the EMT in OSCC. 
The serine/threonine protein kinase Akt is a down-
stream effector of phosphatidylinositol 3-kinase (PI3K) 
and is frequently activated in human cancers (26). p-
Akt was found to be an independent prognostic factor in 
patients with OSCC (31), and has recently been linked 
with the conversion of a potentially malignant oral le-
sion to OSCC (9). Pontes et al. (9) demonstrated that p-
Akt expression in OSCC in significantly increased when 
compared to epithelial dysplasia and normal epithelium, 
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suggesting that p-Akt expression can be an early event 
in cases of dysplastic lesions progressing to oral cancer. 
These results are in accordance to the obtained in the 
present study, where p-Akt immunoexpression was sig-
nificantly increased in OSCC if compared with normal 
oral mucosa and OL. 
In the current evaluation, p-Akt immunoexpression was 
found in the nucleus and cytoplasm. In normal oral mu-
cosa and OL, p-Akt staining was restricted to the nucleus, 
whereas in OSCC p-Akt immunoexpression was found 
in both compartments, with a predominance of cytoplas-
matic immunoreactivity in the less differentiated tumors. 
According to Amornphimoltham et al. (31) p-Akt can 
be detected in head and neck carcinogenesis with a pat-
tern of expression and localization that correlates with 
the progression of the malignant process (normal epithe-
lium, epithelial dysplasia, carcinoma in situ and OSCC). 
Indeed, they found that in normal epithelium the stain-
ing was limited to the basal and parabasal cell layers and 
always confined to the nucleus. In dysplastic areas they 
reported that the cells presented a strong nuclear staining, 
whereas in situ carcinoma revealed nuclear and cytoplas-
matic staining. However, only in a few cases of invasive 
OSCC, p-Akt staining was nuclear; in most instances it 
was predominantly cytoplasmatic.
TWIST expression in parabasal and basal layers of OL 
groups associated with acquisition of an dysplastic phe-
notype at this region and the positive correlation between 
TWIST and p-Akt expression, found in this study, sug-
gests that it may participate of oral carcinogenesis since 
early stages. However, the exact mechanism of this inter-
action requires further investigation. 
In conclusion, the results obtained in the current study sug-
gest that TWIST and p-Akt may participate in the process 
of malignant transformation of oral epithelium since early 
stages of oral carcinogenesis process. Additionally, the 
high expression of TWIST and p-Akt in OSCC suggests 
that these proteins might be important targets for therapeu-
tic approaches in patients affected by OSCC.
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